Nils Hoyer

803 total citations
31 papers, 486 citations indexed

About

Nils Hoyer is a scholar working on Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Physiology. According to data from OpenAlex, Nils Hoyer has authored 31 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 5 papers in Public Health, Environmental and Occupational Health and 4 papers in Physiology. Recurrent topics in Nils Hoyer's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (23 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (14 papers) and Respiratory Support and Mechanisms (4 papers). Nils Hoyer is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (23 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (14 papers) and Respiratory Support and Mechanisms (4 papers). Nils Hoyer collaborates with scholars based in Denmark, United Kingdom and Norway. Nils Hoyer's co-authors include Saher Burhan Shaker, Elisabeth Bendstrup, Thomas Skovhus Prior, Torgny Wilcke, Ole Hilberg, Jesper Rømhild Davidsen, Laura H. Thomsen, Diana Julie Leeming, Zitta Barrella Harboe and Tomas Ø. Jensen and has published in prestigious journals such as Frontiers in Immunology, European Respiratory Journal and Thorax.

In The Last Decade

Nils Hoyer

28 papers receiving 478 citations

Peers

Countries citing papers authored by Nils Hoyer

Since Specialization

Citations

This map shows the geographic impact of Nils Hoyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nils Hoyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nils Hoyer more than expected).

Fields of papers citing papers by Nils Hoyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nils Hoyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nils Hoyer. The network helps show where Nils Hoyer may publish in the future.

Co-authorship network of co-authors of Nils Hoyer

This figure shows the co-authorship network connecting the top 25 collaborators of Nils Hoyer. A scholar is included among the top collaborators of Nils Hoyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nils Hoyer. Nils Hoyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Basement membrane repair response biomarker PRO-C4 predicts progression in idiopathic pulmonary fibrosis: analysis of the PFBIO and PROFILE cohorts 2025 ·Thorax ·Jannie Marie Bülow Sand, Peder Frederiksen, Alison E. John, (unknown), Nils Hoyer, Thomas Skovhus Prior, Adnan Avdic-Belltheus, Philip L. Molyneaux, Iain Stewart, Hernan P. Fainberg, Simon R. Johnson, M.A. Karsdal, Diana Julie Leeming, Elisabeth Bendstrup, Saher Burhan Shaker, Toby M. Maher, Gísli Jenkins	0
2	Fibroblast activation protein and disease severity, progression, and survival in idiopathic pulmonary fibrosis 2024 ·Scandinavian Journal of Immunology ·Thomas Skovhus Prior, Nils Hoyer, Jesper Rømhild Davidsen, Saher Burhan Shaker, (unknown), (unknown), Bent Deleuran, Elisabeth Bendstrup, Tue Wenzel Kragstrup	2
3	Impact of reduction in antifibrotic treatment on mortality in idiopathic pulmonary fibrosis 2022 ·Respiratory Medicine ·(unknown), Nils Hoyer, Saher Burhan Shaker	4
4	Turnover of type I and III collagen predicts progression of idiopathic pulmonary fibrosis 2021 ·Respiratory Research ·(unknown), Nils Hoyer, Thomas Skovhus Prior, Peder Frederiksen, M.A. Karsdal, Diana Julie Leeming, Elisabeth Bendstrup, Jannie Marie Bülow Sand, S. B. Shaker	39
5	Longitudinal serological assessment of type VI collagen turnover is related to progression in a real-world cohort of idiopathic pulmonary fibrosis 2021 ·BMC Pulmonary Medicine ·(unknown), Nils Hoyer, Thomas Skovhus Prior, Peder Frederiksen, Sarah Rank Rønnow, M.A. Karsdal, Diana Julie Leeming, Elisabeth Bendstrup, Jannie Marie Bülow Sand, Saher Burhan Shaker	12
6	Clusters of comorbidities in idiopathic pulmonary fibrosis 2021 ·Respiratory Medicine ·Thomas Skovhus Prior, Nils Hoyer, Ole Hilberg, Saher Burhan Shaker, Jesper Rømhild Davidsen, Finn Rasmussen, Elisabeth Bendstrup	16
7	Validation of a derived version of the IPF-specific Saint George’s Respiratory Questionnaire 2021 ·Respiratory Research ·Thomas Skovhus Prior, Nils Hoyer, Saher Burhan Shaker, Jesper Rømhild Davidsen, Ole Hilberg, Haridarshan Patel, Elisabeth Bendstrup	4
8	Evaluation of Extracellular Matrix Biomarkers in Response to Anti-Fibrotic Treatment of Idiopathic Pulmonary Fibrosis 2020 ·(unknown), Nils Hoyer, Sarah Rank Rønnow, M.A. Karsdal, Diana Julie Leeming, Jannie Marie Bülow Sand, (unknown)	1
9	TOB-STOP-COP (TOBacco STOP in COPd trial): study protocol—a randomized open-label, superiority, multicenter, two-arm intervention study of the effect of “high-intensity” vs. “low-intensity” smoking cessation intervention in active smokers with chronic obstructive pulmonary disease 2020 ·Trials ·(unknown), Pradeesh Sivapalan, Josefin Eklöf, Charlotte Suppli Ulrik, Charlotta Pisinger, Thérèse Lapperre, Philip Tønnesen, Nils Hoyer, Julie Janner, (unknown), (unknown), (unknown), Nina Godtfredsen, Eva Brøndum, (unknown), (unknown), (unknown), (unknown), Jens‐Ulrik Stæhr Jensen	6
10	Increased respiratory morbidity in individuals with interstitial lung abnormalities 2020 ·BMC Pulmonary Medicine ·Nils Hoyer, Laura H. Thomsen, Mathilde Marie Winkler Wille, Torgny Wilcke, Asger Dirksen, Jesper Holst Pedersen, Zaigham Saghir, Haseem Ashraf, Saher Burhan Shaker	16
11	Responsiveness and minimal clinically important difference of SGRQ-I and K-BILD in idiopathic pulmonary fibrosis 2020 ·Respiratory Research ·Thomas Skovhus Prior, Nils Hoyer, Ole Hilberg, Saher Burhan Shaker, Jesper Rømhild Davidsen, Elisabeth Bendstrup	27
12	Silent hypoxia in patients with SARS CoV-2 infection before hospital discharge 2020 ·International Journal of Infectious Diseases ·(unknown), Tomas Ø. Jensen, Nils Hoyer, Camilla Koch Ryrsø, Birgitte Lindegaard, Zitta Barrella Harboe	46
13	Validation of the IPF-specific version of St. George’s Respiratory Questionnaire 2019 ·Respiratory Research ·Thomas Skovhus Prior, Nils Hoyer, Saher Burhan Shaker, Jesper Rømhild Davidsen, Janelle Yorke, Ole Hilberg, Elisabeth Bendstrup	40
14	Risk factors for diagnostic delay in idiopathic pulmonary fibrosis 2019 ·Respiratory Research ·Nils Hoyer, Thomas Skovhus Prior, Elisabeth Bendstrup, Torgny Wilcke, Saher Burhan Shaker	94
15	Validation of the IPF-specific version of St. George’s Respiratory Questionnaire in Danish 2019 ·University of Southern Denmark Research Portal (University of Southern Denmark) ·Thomas Skovhus Prior, Nils Hoyer, Saher Burhan Shaker, Jesper Rømhild Davidsen, Janelle Yorke, Ole Hilberg, Elisabeth Bendstrup	1
16	Validation of the King’s Brief Interstitial Lung Disease questionnaire in Idiopathic Pulmonary Fibrosis 2019 ·BMC Pulmonary Medicine ·Thomas Skovhus Prior, Ole Hilberg, Saher Burhan Shaker, Jesper Rømhild Davidsen, Nils Hoyer, Surinder S. Birring, Elisabeth Bendstrup	24
17	Risk factors for chronic pulmonary aspergillosis in a low prevalence country and their effect on survival 2015 ·Nils Hoyer, Jørgen Vestbo	0
18	Effects of the vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor SU5416 on in vitro cultures of Plasmodium falciparum 2014 ·Malaria Journal ·Casper Hempel, Nils Hoyer, Trine Staalsøe, Jørgen A. L. Kurtzhals	12
19	Routine chest radiograph is still valuable in patients admitted for acute non-traumatic chest pain, an observational study 2014 ·European Respiratory Journal ·Nils Hoyer, Ida Steffensen, Mikkel Malby Schoos, Martin Schønemann‐Lund, Rolf Steffensen	1
20	Systemic and Cerebral Vascular Endothelial Growth Factor Levels Increase in Murine Cerebral Malaria along with Increased Calpain and Caspase Activity and Can be Reduced by Erythropoietin Treatment 2014 ·Frontiers in Immunology ·Casper Hempel, Nils Hoyer, (unknown), (unknown), Jørgen A. L. Kurtzhals	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact